These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23376063)

  • 1. Dendritic cells: an important link between antiphospholipid antibodies, endothelial dysfunction, and atherosclerosis in autoimmune and non-autoimmune diseases.
    Broder A; Chan JJ; Putterman C
    Clin Immunol; 2013 Mar; 146(3):197-206. PubMed ID: 23376063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibody syndrome and autoimmune diseases.
    Ostrowski RA; Robinson JA
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):53-65, vi. PubMed ID: 18207065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of disease: atherosclerosis in autoimmune diseases.
    Sherer Y; Shoenfeld Y
    Nat Clin Pract Rheumatol; 2006 Feb; 2(2):99-106. PubMed ID: 16932663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerosis and the antiphospholipid syndrome: a link unravelled?
    Shoenfeld Y; Harats D; George J
    Lupus; 1998; 7 Suppl 2():S140-3. PubMed ID: 9814692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis.
    Sherer Y; Shoenfeld Y
    Curr Atheroscler Rep; 2001 Jul; 3(4):328-33. PubMed ID: 11389799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction in rheumatic autoimmune diseases.
    Murdaca G; Colombo BM; Cagnati P; Gulli R; Spanò F; Puppo F
    Atherosclerosis; 2012 Oct; 224(2):309-17. PubMed ID: 22673743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo.
    Pierangeli SS; Colden-Stanfield M; Liu X; Barker JH; Anderson GL; Harris EN
    Circulation; 1999 Apr; 99(15):1997-2002. PubMed ID: 10209004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies bind to activated but not resting endothelial cells: is an independent triggering event required to induce antiphospholipid antibody-mediated disease?
    Chen Q; Stone PR; Woon ST; Ching LM; Hung S; McCowan LM; Chamley LW
    Thromb Res; 2004; 114(2):101-11. PubMed ID: 15306152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity patterns of antiphospholipid antibodies and endothelial cells: effect of antiendothelial antibodies on cell migration.
    Lanir N; Zilberman M; Yron I; Tennenbaum G; Shechter Y; Brenner B
    J Lab Clin Med; 1998 Jun; 131(6):548-56. PubMed ID: 9626990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis, antiphospholipid syndrome, and antiphospholipid antibodies.
    Nicolo D; Varadhachary AS; Monestier M
    Front Biosci; 2007 Jan; 12():2171-82. PubMed ID: 17127454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic antiphospholipid syndrome and atherosclerosis.
    Jara LJ; Medina G; Vera-Lastra O
    Clin Rev Allergy Immunol; 2007 Apr; 32(2):172-7. PubMed ID: 17916989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibodies and thrombosis.
    Brighton TA; Chesterman CN
    Baillieres Clin Haematol; 1994 Sep; 7(3):541-57. PubMed ID: 7841600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated atheroma in the antiphospholipid syndrome.
    Matsuura E; Kobayashi K; Tabuchi M; Lopez LR
    Rheum Dis Clin North Am; 2006 Aug; 32(3):537-51. PubMed ID: 16880083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid and antiendothelial antibodies.
    Meroni PL; Del Papa N; Borghi MO
    Int Arch Allergy Immunol; 1996 Dec; 111(4):320-5. PubMed ID: 8957103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac manifestations in antiphospholipid syndrome.
    Soltész P; Szekanecz Z; Kiss E; Shoenfeld Y
    Autoimmun Rev; 2007 Jun; 6(6):379-86. PubMed ID: 17537384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells.
    Pierangeli SS; Harris EN
    Lupus; 2003; 12(7):539-45. PubMed ID: 12892395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
    Narshi CB; Giles IP; Rahman A
    Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study.
    Di Minno MND; Emmi G; Ambrosino P; Scalera A; Tufano A; Cafaro G; Peluso R; Bettiol A; Di Scala G; Silvestri E; Prisco D
    Int J Cardiol; 2019 Jan; 274():1-6. PubMed ID: 30454720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmacytoid dendritic cells: biomarkers or potential therapeutic targets in atherosclerosis?
    Grassia G; MacRitchie N; Platt AM; Brewer JM; Garside P; Maffia P
    Pharmacol Ther; 2013 Feb; 137(2):172-82. PubMed ID: 23059425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.